Rockwell Medical to suspend pharma development, concentrate on revenue
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), the Wixom-based developer of products for patients suffering from blood and kidney disorders, announced it would suspend develop of new pharmaceutical products, and concentrate instead …